Far Infrared Radiation Treatment for Diabetes

GAAD Medical Research Institute Inc.

Status and phase: Unknown; Phase 1

Conditions: Diabetes Mellitus

Treatments: Radiation: Far Infrared Radiation

Study type: Interventional

Funder types: Other

Identifiers

NCT00573456

GAAD-DM-CTP1

Details and patient eligibility

About

A study to determine the use of far infrared (FIR) radiation for treatment of diabetes.

Full description

Diabetes mellitus is a disease in which glucose is not sufficiently metabolized. This results in high glucose levels in blood and glucose in the urine. Cells can starve because glucose is not being metabolized.

Both types of diabetes can cause dangerous complications, including blindness, heart and blood vessel disease, and kidney failure. A decrease in circulation may eventually require the amputation of limbs.

We are postulating that energy specific electromagnetic radiation of the central nervous system, the viscera and the endocrine system has the potential to enhance the immune system; thereby improving the health of the patients.

Enrollment: 2 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Persons with type 1 or type 2 diabetes

Exclusion criteria

• None

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

2 participants in 1 patient group

1

Other group

Treatment:

Radiation: Far Infrared Radiation